Biolife Solutions (BLFS) Receivables (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Receivables data on file, last reported at $13.1 million in Q1 2026.

• On a quarterly basis, Receivables rose 42.43% year-over-year to $13.1 million in Q1 2026; TTM through Mar 2026 was $13.1 million, a 42.43% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, down 6.17% from the prior year.
• Receivables for Q1 2026 stood at $13.1 million, up from $8.0 million in the prior quarter.
• Over the last five years, Receivables for BLFS reached as high as $33.9 million in Q4 2022 and fell as low as $7.9 million in Q4 2023.
• Historically, Receivables has averaged $19.2 million across 5 years, with a median of $18.1 million in 2024.
• Across the five-year window, Receivables soared 127.49% in 2022 and tumbled 76.73% in 2023, its largest moves.
• Year by year, Receivables stood at $33.9 million in 2022, then tumbled by 76.73% to $7.9 million in 2023, then gained by 7.32% to $8.5 million in 2024, then fell by 6.17% to $8.0 million in 2025, then surged by 64.18% to $13.1 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $13.1 million in Q1 2026, $8.0 million in Q4 2025, and $10.8 million in Q3 2025.